Nurix Therapeutics (NRIX) Other Non-Current Assets (2019 - 2026)

Nurix Therapeutics (NRIX) has 8 years of Other Non-Current Assets data on file, last reported at $968000.0 in Q2 2026.

• On a quarterly basis, Other Non-Current Assets rose 7.44% year-over-year to $968000.0 in Q2 2026; TTM through May 2026 was $968000.0, a 7.44% increase from a year earlier, with the FY2025 full-year figure at $7.3 million, up 132.38% from the prior year.
• Other Non-Current Assets for Q2 2026 stood at $968000.0, roughly flat from $968000.0 in the prior quarter.
• Over the last five years, Other Non-Current Assets for NRIX reached as high as $7.3 million in Q4 2025 and fell as low as $901000.0 in Q1 2022.
• Historically, Other Non-Current Assets has averaged $1.4 million across 5 years, with a median of $901000.0 in 2022.
• Across the five-year window, Other Non-Current Assets slumped 67.18% in 2022 and surged 250.61% in 2024, its largest moves.
• Year by year, Other Non-Current Assets stood at $901000.0 in 2022, then changed by 0.0% to $901000.0 in 2023, then jumped by 250.61% to $3.2 million in 2024, then surged by 132.38% to $7.3 million in 2025, then plunged by 86.81% to $968000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $968000.0 in Q2 2026, $968000.0 in Q1 2026, and $7.3 million in Q4 2025.